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Abstract 
In recent years, the rapid development of medical and pharmacological 
interventions has led to a steady decline in certain noncommunicable chronic diseases 
(NCDs), such as cancer. However, the overall incidence of cardiovascular diseases 
(CVDs) has not seemed to decline. CVDs have become even more prevalent in many 
countries and represent a global health threat and financial burden. An increasing 
number of epidemiological and experimental studies have demonstrated that maternal 
insults not only can result in birth defects but also can cause developmental functional 
defects that contribute to adult NCDs. In the current review, we provide an overview 
of evidence from both epidemiological investigations and experimental animal studies 
supporting the concept of developmental reprogramming of adult CVDs in offspring 
that have experienced prenatal inflammation exposure (PIE) during fetal development 
(PIE-programmed CVDs), a disease-causing event that has not been effectively 
controlled. This review describes the epidemiological observations, data from animal 
models, and related mechanisms for the pathogenesis of PIE-programmed CVDs. In 
addition, the potential therapeutic interventions of PIE-programmed CVDs are 
discussed. Finally, we also deliberate the need for future mechanistic studies and 
biomarker screenings in this important field, which creates a great opportunity to 
combat the global increase in CVDs by managing the adverse effects of inflammation 
for prepregnant and pregnant individuals who are at risk for PIE-programmed CVDs.  
Keywords: Cardiovascular diseases; inflammation; prenatal inflammatory exposure; 
maternal immune activation; developmental reprogramming; NF-κB. 
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Abbreviations:  
ACE, Angiotensin-converting enzyme; ACTH, Adrenocorticotropic hormone; Ang II, 
Angiotensin II; ApoE, Apolipoprotein E; AT1R, Ang II type 1 receptor; AT2R, Ang II 
type 2 receptor; AVP, Arginine vasopressin; CMV, Cytomegalovirus; CNS, Central 
nervous system; CRH, Corticotropin-releasing hormone; CVDs, Cardiovascular 
diseases; DHA, Dehydroacetic acid; DNMT, DNA methyltransferase; DOCA, 
Deoxycorticosterone acetate; DOHaD, Developmental origins of health and disease; 
GHO, Global Health Observatory; GPCR, G protein-coupled receptor; GR, 
Glucocorticoid receptor; HBV, Hepatitis B virus; HIV, Human immunodeﬁciency 
virus; HPA, Hypothalamic-pituitary-adrenal; HPV, Human papillomavirus; HRV, 
Human rhinovirus; HSCs, Hematopoietic stem cells; HSD, Hydroxysteroid 
dehydrogenase; HSV, Herpes simplex virus; IFN, Interferon; IL, Interleukin; ISO, 
Isoproterenol; LPS, Lipopolysaccharide; MAPK, Mitogen-activated protein kinase; 
NCDs, Noncommunicable diseases; PDTC, Pyrrolidine dithiocarbamate; PGC-1α, 
Peroxisome proliferator-activated receptor-γ coactivator 1α; PIE, Prenatal 
inflammation exposure; PVN, Paraventricular nucleus; RAS, Renin–angiotensin 
system; ROS, Reactive oxygen species; SAM, Sympathetic adrenal medullary; TLR, 
Toll- like receptor; TNF, Tumor necrosis factor; Treg, Regulatory T cell; WHO, World 
Health Organization. 
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1. Introduction 
With the decreased prevalence of communicable diseases worldwide, 
noncommunicable diseases (NCDs) have become the greatest threat and burden of 
global health expenses, particularly in developing countries and regions that are 
undergoing socioeconomic transition. NCDs mainly include cardiovascular diseases 
(CVDs), cancers, respiratory diseases, diabetes and various metabolic diseases, which 
account for over 70% of global deaths (39.5 million of 56.4 million global deaths), 
according to the 2015 Global Health Observatory (GHO) of the World Health 
Organization (WHO) (Mendis, Davis, & Norrving, 2015). Among NCDs, CVDs are 
the leading causes of death (17.7 million deaths in 2015; 45% of all NCD deaths) 
(Mendis, et al., 2015). The clinical therapies and preventive measures for CVDs have 
become one of the highest expenditures in health care systems around the world in the 
efforts to combat all forms of NCDs (Laslett, et al., 2012). However, the incidence 
and mortality of CVDs continue to rise rapidly worldwide, and even the treatment 
strategies toward managing traditional risk factors, such as lipid levels and blood 
pressure, show significant beneficial effects in the secondary prevention of CVDs 
(Gaita & Sperling, 2015). CVD risk factors, such as hypertension, hyperglycemia, 
Type II diabetes, dyslipidemia, atherosclerosis, and metabolic syndrome, are now 
more prevalent in adults and even in adolescents into the 21st century (Alvarez, Vieira, 
Sichieri, & Veiga, 2011; Eisenmann, 2003). All of this evidence indicates that other 
potential critical factors responsible for CVDs were overlooked in the past. The 
current dominant scientific opinion assumes that genetic predisposition coupled with 
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adult lifestyle contributes to the development of CVDs; however, adult lifestyle 
changes and weight loss have been relatively unsuccessful in reducing the burden of 
CVDs at the public health level (Hanson & Gluckman, 2014).  
In the past several decades, extensive epidemiological investigations and 
experimental animal studies have demonstrated that early- life environmental insults, 
such as maternal exposure to smoking, nicotine, ethanol and caffeine, as well as 
several maternal disease conditions, such as obesity, bacterial vaginitis, stress, and 
malnutrition, contribute to an increased risk of NCDs, a process that is termed the 
developmental origins of health and disease (DOHaD) (D. J. Barker, 2004; D. J. 
Barker, Osmond, Forsen, Kajantie, & Eriksson, 2005; Costa-Silva, et al., 2015; 
Hanson & Gluckman, 2014; McMillen & Robinson, 2005). Given the practical 
constraints of prospective studies and the limited evidence from retrospective studies, 
the concept of DOHaD may have been largely overlooked in the past two decades but 
has received much attention in light of the recent, rapidly accumulating evidence from 
a series of epidemiological investigations and animal model-based studies (D. Barker, 
Barker, Fleming, & Lampl, 2013; Hanson & Gluckman, 2014; Rando & Simmons, 
2015). This concept of DOHaD has a great implication for our understanding of the 
etiologies and disease-causing mechanisms of many forms of NCDs, including CVDs 
(Hanson & Gluckman, 2014). 
Prenatal inflammation exposure (PIE) has been brought to our attention for more 
than ten years. The inflammation can be caused by 1) the classic inflammatory 
pathway, also called “hot” inflammation, which is driven by pathogens usually 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
accompanied by a febrile reaction, such as found in viral, bacterial and parasitic 
infections (Calay & Hotamisligil, 2013) or 2) an unknown etiology with a chronic and 
relatively lower degree of inflammation, such as chronic inflammation from the 
placenta and metabolic inflammation (called “metaflammation”), that is not 
accompanied by an increased basal energy expenditure—also called “cold” 
inflammation (Calay & Hotamisligil, 2013). Autoimmune diseases, such as systemic 
lupus erythematosus, result in chronic inflammation and yield a multitude of adverse 
reproductive and obstetric outcomes (Oktem, Yagmur, Bengisu, & Urman, 2016). 
Both maternal “hot” and “cold” inflammatory conditions can lead to an increased 
incidence of CVDs in offspring; as such, we named this category “PIE-programmed 
CVDs”. In this review, we will discuss the concept derived from epidemiological and 
experimental studies and the potential mechanisms for PIE-programed CVDs. We 
hope this analysis will help to understand the overall physiological and 
pathophysiological bases for PIE-programmed CVDs and to create potential, effective 
strategies for the early intervention of PIE-programmed CVDs.  
 
2. Epidemiological evidence supporting “PIE-programmed CVDs” 
CVDs, which mainly include ischemic heart disease, stroke, hypertensive heart 
disease, cardiomyopathies, rheumatic heart disease, atrial fibrillation, aort ic aneurysm, 
peripheral vascular disease, and endocarditis, currently contribute most to the total 
global burden of disease (Moran, Roth, Narula, & Mensah, 2014). PIE remains an 
important unresolved public health problem worldwide, including the 
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abovementioned “hot inflammation” driven by pathogens  (Bastek, Weber, McShea, 
Ryan, & Elovitz, 2014; Gorgas, 2008; Gravett, et al., 2012) and “cold inflammation” 
(Kim, Romero, Chaemsaithong, & Kim, 2015) caused by obesity, diabetes and other 
metabolic diseases (Calay & Hotamisligil, 2013). The initial evidence of maternal 
inflammation contributing to CVDs comes from association analyses showing that 
inflammatory diseases during pregnancy are commonly associated with low birth 
weight and preterm birth (Boggess, Beck, Murtha, Moss, & Offenbacher, 2006; Hay, 
et al., 1994), which is prone to cause an increased incidence of CVDs in offspring 
(Arends, et al., 2005; de Boo & Harding, 2006; Eriksson, 2016). One remarkable 
observation comes from a series of studies on the population born during the period of 
the influenza pandemic in 1918; this pool of the population has a significant increased 
level of CVDs (Cocoros, et al., 2014; Mazumder, Almond, Park, Crimmins, & Finch, 
2010; Myrskyla, Mehta, & Chang, 2013) (Fig. 1).  
 
2.1 Maternal hot inflammation and PIE-programed CVDs 
Strong evidence to support the notion that maternal inflammation is causally 
associated with CVDs came from a series of studies of offspring in the influenza 
pandemic era, which was further supported by observations that maternal influenza 
exposure (Acs, Banhidy, Puho, & Czeizel, 2005; Ou, et al., 2016) and febrile 
genitourinary infections (Botto, et al., 2014) cause cardiovascular malformations in 
the fetus. In 2010, a retrospective study of 1918–1919 influenza pandemic (Influenza 
A, H1N1 subtype) cohorts (over 101,068 individuals) in the United States that was 
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conducted by the National Center for Health Statistics (USA) revealed that prenatal 
influenza infection was closely associated with a ≥ 20% excess amount of CVDs, 
including ischemic heart disease and diabetes in 62-82-year-old individuals, relative 
to cohorts born without exposure to the influenza (Mazumder, et al., 2010). This study 
found that the population born in the first quarter of 1919 that was exposed to the 
influenza in the second trimester of pregnancy had an overall 10.9% excess of heart 
disease, with 25.4% excess ischemic heart disease and 20.8% excess diabetes 
compared to the cohorts born in other periods of this influenza epidemic. Gender 
differences showed differential birth quarter effects, with only men born in the first 
quarter of 1919 having a significantly higher percentage of total heart diseases 
(23.1%), with more ischemic heart diseases (32.7%) and hypertensive heart diseases 
(21.6%) compared to women (Mazumder, et al., 2010). Another independent study in 
the United States, conducted by the National Health Interview Survey, also confirmed 
the above findings that prenatal influenza exposure resulted in an increased incidence 
of CVDs. However, the study revealed that the cohorts exposed to the second or third 
waves of influenza during early gestation had decreased risk levels for developing 
CVDs (Myrskyla, et al., 2013). Recently, another study of a Danish cohort reported 
that the overall incidence of myocardial infarction showed an increased trend in the 
1918 and 1968 influenza pandemic cohorts, despite lacking statistical significance 
(Cocoros, et al., 2014), which might be attributed to the ungroup analysis based on the 
specified exposure time during pregnancy. Taken together, these findings suggest that 
the time window of viral exposure during gestation is critical to the development of 
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future CVDs, of which the second trimester might be the most important window (Fig. 
1 and Table 1). 
 
2.2 Maternal cold inflammation and PIE-programed CVDs  
Cold inflammation is the consequence of disease conditions such as obesity, 
maternal diabetes or hyperglycemia, hypertension, preeclampsia, and smoking. 
Several studies have shown that maternal cold inflammation has a significant positive 
correlation with CVDs in offspring. Maternal pre-pregnancy obesity, diabetes and 
excessive gestational weight gain, whose inflammatory pathways are activated 
(Burton, Fowden, & Thornburg, 2016) together with macrophage accumulation and 
inflammation in the placenta (Challier, et al., 2008), are considered important risk 
factors for the development of cardiovascular and metabolic diseases in early 
postnatal life and adulthood. This topic has been extensively reviewed in several 
recent publications (Aceti, et al., 2012; Costa-Silva, Simoes-Alves, & Fernandes, 
2016; Ma, Tutino, Lillycrop, Hanson, & Tam, 2015; Roberts, Frias, & Grove, 2015). 
Early onset of maternal higher blood pressure or preeclampsia during pregnancy can 
lead to an imbalance between inflammatory and anti-inflammatory profiles in CD4+ T 
cell subsets, accompanied by higher plasma levels of interleukin-6 (IL-6), IL-17 and 
tumor necrosis factor (TNF)-α in mothers (Ribeiro, et al., 2017). This imbalance can 
affect early childhood blood pressures and cardiovascular health in the offspring. For 
example, the GUSTO Birth Cohort Study showed that the peripheral systolic blood 
pressure of offspring increased by 0.08 mmHg at 3 years of age with every 1 mmHg 
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increase in the maternal central systolic blood pressure; another study found that the 
systolic blood pressure of offspring born to mothers with early-onset preeclampsia 
increased by 7.88 mmHg compared with those born to mothers with late-onset 
preeclampsia at the age of 6 to 13 years. (Himmelmann, Svensson, & Hansson, 1993, 
1994; Jayet, et al., 2010; Lazdam, et al., 2012; Lim, et al., 2015; Tenhola, Rahiala, 
Halonen, Vanninen, & Voutilainen, 2006). Maternal smoking or even second-hand 
smoke exposure, causing a proinflammatory status including elevated maternal serum 
levels of TNF-α and interleukin (IL)-1β (Niu, et al., 2017; Niu, et al., 2016), is 
recognized as an independent risk factor for CVDs (Behl, et al., 2013; Cohen, Vella, 
Jeffery, Lagercrantz, & Katz-Salamon, 2008; Lawlor, et al., 2004). However, the 
direct causal relationship between the maternal cold inflammation and these 
abovementioned diseases needs to be further determined.  
Collectively, the evidence discussed here indicates that both “hot” and “cold” 
maternal inflammation can lead to an increased incidence of CVDs (Fig. 2  and Table 
1).  
 
2.3 Maternal hot and cold inflammation-induced preterm birth and low birth 
weight 
The close link of PIE to offspring CVDs can also be traced from the close 
association of preterm birth and low birth weight in PIE-offspring, as preterm birth 
and low birth weight are known to be related to the development of CVDs 
(Bertagnolli, Luu, Lewandowski, Leeson, & Nuyt, 2016; Eriksson, 2016; Ligi, 
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Grandvuillemin, Andres, Dignat-George, & Simeoni, 2010; Norman, 2010) (Fig. 1 
and Fig. 2). There are many epidemiological observations that maternal viral 
infections are closely related to preterm birth and low birth weight. For example, 
individuals infected with influenza produce a lower proportion of preterm births 
(8.0%) and low birth weight newborns (4.7%) (Acs, Banhidy, Puho, & Czeizel, 2006; 
Doyle, Goodin, & Hamilton, 2013; S. S. Lee & Wong, 2012); women with circulating 
hepatitis B virus (HBV) DNA show a higher proportion of spontaneous preterm births 
(7.3%) than women without HBV infection (1.6%) (Elefsiniotis, et al., 2010; 
Mouloudi, et al., 2012; Sirilert, Traisrisilp, Sirivatanapa, & Tongsong, 2014); the 
incidence of preterm delivery is 19.7% in human immunodeﬁciency virus 
(HIV)- infected women and 8.5% in healthy women (López, et al., 2016; Lopez, et al., 
2012; Lopez, et al., 2015; Rollins, et al., 2007; Uneke, Duhlinska, & Ujam, 2009); 
prematurity is 77% higher in infants of mothers with malaria caused by Plasmodium 
falciparum than in infants of mothers with malaria by caused by Plasmodium vivax 
(Botto-Menezes, et al., 2015; Nair & Nair, 1993; Tobon-Castano, Solano, Sanchez, & 
Trujillo, 2011). In addition, urogenital infections during pregnancy, such as bacterial 
vaginosis (Klebanoff, et al., 2005), placental malaria infection (Menendez, et al., 2000; 
Oraneli, Okeke, & Ubachukwu, 2013), Chlamydia trachomatis infection (Baud, et al., 
2015; Rours, et al., 2011), schistosomiasis (Mombo-Ngoma, et al., 2017), 
Mycoplasma hominis (Paul, et al., 1998), Ureaplasma parvum infection (Agger, et al., 
2014), and sexually transmitted diseases (H. L. Johnson, Ghanem, Zenilman, & 
Erbelding, 2011), also show a close association with preterm birth and low birth 
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weight. Other inflammatory diseases without an undefined pathogen infection during 
pregnancy, including chorioamnionitis (Botet, Figueras, Carbonell-Estrany, Arca, & 
The Castrillo Study, 2010; Botet, Figueras, Carbonell-Estrany, & Narbona, 2011), 
intra-amniotic inﬂammation (Shim, et al., 2004), periodontitis (Kumar, et al., 2013; 
Lauren, Minire, Maldi, Mirton, & Aferdita, 2012; Macedo, et al., 2014), systemic 
lupus erythematosus (Clark, Spitzer, Nadler, & Laskin, 2003; M. J. Johnson, Petri, 
Witter, & Repke, 1995), and primary sclerosing cholangitis (Ilhan, Ilhan, Gok, Gunay, 
& Ertekin, 2016; Ludvigsson, et al., 2014), have also been reported to cause preterm 
birth and low birth weight.  
 
3. Development of experimental animal models for PIE-programmed CVDs 
Experimental animal models for PIE-programed CVDs were established in 2004 
by treating pregnant rats with human IL-6 during the entire second or third trimester 
(Samuelsson, et al., 2004). IL-6 is known as one of the critical proinflammatory 
cytokines produced by various cell types after immune activation or in a chronic 
disease status (Hunter & Jones, 2015). Offspring from mothers that were treated with 
9 μg/kg recombinant human IL-6 on gestational days 8, 10 and 12 (in the second 
trimester) or on days 16, 18 and 20 (in the third trimester) showed a higher blood 
pressure at 5 weeks of age and eventually developed hypertension (increased by over 
40 mmHg at 24 weeks of age) and an increased heart rate by 11 weeks of age 
(Samuelsson, et al., 2006; Samuelsson, et al., 2004) (Fig. 3 and Table 2).  
To better mimic the complexity of persistent maternal inflammatory stimulation 
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in vivo, our laboratory developed a protocol by treating pregnant rats or mice with a 
lower dose of lipopolysaccharide (LPS), a main component of the gram-negative 
bacterial cellular wall and a specific ligand for Toll- like receptor (TLR) 4, to serve as 
a nonspecific immunostimulant of bacterial infection (Lien, et al., 2000). We also 
developed a similar model mimicking a fungal infection-mediated inflammatory 
response by treating animals with zymosan, a key component of yeast cell walls and a 
specific ligand for TLR2/6 (Volman, Hendriks, & Goris, 2005). Similar to IL-6 
treatment, treating pregnant rats with LPS or zymosan on gestational days 8, 10 and 
12 was able to effectively increase blood pressure levels (increased by 8.0 mmHg) in 
the offspring by 6 weeks of age and eventually caused hypertension (increased by 40 
mmHg) at an older age (Liao, et al., 2008; Y. L. Wei, Li, & Zhou, 2007) (Fig. 3). The 
offspring also demonstrated pathological alterations in their vascular structure at the 
neonatal stage and finally progressed to significant dysfunctions in adulthood (S. 
Zhao, Zhang, Cao, Liu, & Li, 2014). In addition, animals that were maternally 
exposed to LPS or zymosan had increased levels of myocardial fibrosis and 
myocardial remodeling (Chen, et al., 2015; Y. Wei, et al., 2013), significantly reduced 
glomerular numbers and creatinine clearance rates, but higher urinary protein levels, 
indicating renal injury (Hao, Zhang, Yuan, et al., 2010) (Fig. 4). Our ongoing studies 
indicated that a short-term- or transient-stimulus inflammatory challenge by using a 
one-time LPS or poly (I:C) (a synthetic double-stranded RNA that mimics a viral 
infection) treatment on gestational day 10 was also able to increase the blood pressure 
levels in rat offspring [Ji, Deng, et al., unpublished observation]. As previous findings 
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showed that poly(I:C) injection with different dosages and at different time points 
during pregnancy could lead to different outcomes of behavioral abnormalities by 
perturbing brain development at different stages (Chow, Yan, & Wu, 2016; Meyer, 
Feldon, Schedlowski, & Yee, 2005), it would be interesting to systematically 
characterize the different dosages and different time points of prenatal LPS or poly 
(I:C) challenge on the development of PIE-programed CVDs (Table 2).  
It has been postulated that a “multihit” mechanism (i.e., exposure to multiple risk 
factors prenatally and postnatally) contributes to the induction of various diseases, 
such as autism and schizophrenia (Estes & McAllister, 2016). Consistent with this 
hypothesis, our studies also demonstrated that disease conditions of myocardial 
remodeling (Q. Zhang, et al., 2016), hypertension (Deng, Zhang, et al., 2016) and 
atherosclerosis [Ji, Deng, et al., unpublished observation] are similar to the “multihit” 
mechanism, a combination of prenatal exposure of unwanted inflammatory 
stimulation and postnatal exposure to various pathogenic stresses. For example, adult 
rat offspring with PIE at 20 weeks of age with two weeks of postnatal isoproterenol 
(ISO) challenge, a critical component that can activate the sympathetic nervous 
system and trigger stress- induced cardiomyopathy (Lymperopoulos, Rengo, & Koch, 
2013), displayed augmented left-ventricular systolic dysfunction, cardiac hypertrophy 
and myocardial fibrosis (Q. Zhang, et al., 2016). Furthermore, the offspring with PIE 
at the age of 16 weeks with 4 weeks of deoxycorticosterone acetate (DOCA) and salt 
(DOCA-salt) treatment, an aldosterone analogue that mimicked the 
hyperaldosteronism-induced hypertension (Aronova, Iii, & Zarnegar, 2014), showed a 
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significantly greater hypertensive response leading to increased arterial vascular 
remodeling and endothelial dysfunction in both conduit and resistance vasculature 
(Deng, Zhang, et al., 2016). As such, PIE is likely to serve as a CVD-primer (Fig. 4  
and Table 2). 
 
4. Molecular mechanisms of PIE-programmed CVDs 
The rapidly growing interest in biomedical research to determine the complicated 
molecular pathogenic mechanisms that underlie the early development of various 
NCDs is considered the first and critical step for the eventual identification of 
preventative and therapeutic strategies. Previously, a series of studies identified 
several potential common pathways relevant to PIE-programmed CVDs, including the 
crosstalk among reprogramed inflammatory pathways, oxidative stress, 
over-activation of the renin–angiotensin system (RAS), NF-κB dyshomeostasis,  
epigenetic reprograming, and dysregulation of the immune system and 
hypothalamic-pituitary-adrenal (HPA) axis (Fig. 5).  
 
4.1 Crosstalk among inflammation, oxidative stress, RAS and NF-κB in PIE 
models 
It has been shown that inflammatory responses are synergistically activated with 
oxidative stress and RAS, which play critical roles in the development and 
progression of CVDs, such as hypertension, atherosclerosis, nephropathy, and 
cardiomyopathy (Ayoub, Pothineni, Rutland, Ding, & Mehta, 2017; Guzik & Touyz, 
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2017; Pacurari, Kafoury, Tchounwou, & Ndebele, 2014). Current findings suggest 
that this crosstalk mechanism is involved in the pathogenesis of PIE-programed 
CVDs (Fig. 5).  
4.1.1 Strong inflammatory response in utero and the proinflammatory state in 
the adult cardiovascular system  
Inflammation plays critical roles in the development of CVDs (Marchant, et al., 
2012; McMaster, Kirabo, Madhur, & Harrison, 2015). In PIE models, in addition to 
some proinflammatory cytokines that may cross the placental barrier to the embryo 
(Aaltonen, Heikkinen, Hakala, Laine, & Alanen, 2005; Zaretsky, Alexander, Byrd, & 
Bawdon, 2004), inflammatory cytokines (e.g., TNF-α, IL-1β and IL-6) can be 
robustly activated in embryos shortly after maternal exposure to LPS and poly (I:C) 
(Ashdown, et al., 2006; Cardenas, et al., 2010; Deng, Deng, et al., 2016; Liverman, et 
al., 2006; Urakubo, Jarskog, Lieberman, & Gilmore, 2001). The proinflammatory 
cytokines TNF-α and IL-6 are strong risk factors for PIE-induced CVDs in offspring. 
Prenatal exposure to IL-6 alone was able to result in hypertension in adults 
(Samuelsson, et al., 2004), which is in contrast to IL-6 knockouts, in which 
hypertension induced by angiotensin II and acute stress was attenuated (D. L. Lee, et 
al., 2004; D. L. Lee, et al., 2006). We also have found that offspring from mothers 
receiving maternal LPS stimulation showed modest but significantly increased levels 
of the proinflammatory cytokines IL-6, TNF-α and IL-1β in vascular tissues and 
kidney (Deng, Deng, et al., 2016; Guo, et al., 2016). Our more recent studies further 
revealed that dysregulation of the NF-κB signaling pathway plays a critical role in 
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mediating the elevated inflammatory response and PIE-programmed CVDs (Deng, 
Deng, et al., 2016; Deng, Zhang, et al., 2016). NF-κB is known as a common key 
transcription factor in various inflammatory responses. It is downstream of nearly all 
danger-sensing receptors of innate and adaptive immune systems (Smale, 2012). 
Prenatal exposure to LPS causes NF-κB activation in fetal and adult aortic tissues 
(Deng, Deng, et al., 2016; S. Zhao, et al., 2014), which is likely due to a persistently 
lower level of IκBα (Deng, Deng, et al., 2016), a critical molecule for retaining 
NF-κB dimers in the cytoplasm in an inactive state (Ruland, 2011). Both prenatal or 
postnatal NF-κB inhibition by pyrrolidine dithiocarbamate (PDTC) was able to 
prevent hypertension and alleviate damage to the myocardium (Chen, et al., 2015), 
vasculature system (Deng, Deng, et al., 2016) and kidney (Guo, et al., 2016). 
Dyshomeostasis of NF-κB was found to be associated with abnormal RAS 
overactivation in thoracic aortic tissues (Deng, Deng, et al., 2016), sensitizing the 
offspring to hypertensive damage induced by DOCA-salt through impaired 
peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α)-mediated 
antioxidation (Deng, Zhang, et al., 2016). In addition, PIE in obese pregnant females 
elevated the activity of TLR4/NF-κB signaling in the offspring, which was likely 
responsible for enhanced adipogenesis and insulin resistance in the fetal skeletal 
muscle at late gestation (X. Yan, et al., 2010), and exaggerated atherosclerotic lesions 
of the entire aorta in the offspring through augmenting the periaortic adipose 
tissue-specific proinflammatory response in apolipoprotein E (ApoE)-deficient mice 
(Wakana, et al., 2015). Taken together, all these findings suggest that the 
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NF-κB-mediated inflammatory response plays a critical role, possibly through a 
common pathogenic pathway, in the development of PIE-programed CVDs.  
4.1.2 Oxidative stress 
Reactive oxygen species (ROS), a fundamentally important aspect in cellular 
physiology, are generated by both enzymatic and nonenzymatic systems and are 
scavenged by endogenous antioxidant enzymes (Nathan & Cunningham-Bussel, 
2013). Once the balance between the generation and clearance of ROS is disrupted, 
oxidative stress occurs, which leads to cellular and tissue damage triggering a vicious 
spiral cycle of inflammation and oxidative stress (Niemann, et al., 2017). Oxidative 
stress is involved in the pathogenesis of CVDs (Munzel, et al., 2017; Niemann, et al., 
2017; Sack, Fyhrquist, Saijonmaa, Fuster, & Kovacic, 2017). Mounting evidence has 
shown oxdative stress as pervasive pathological changes in the cardiovascular system 
in offspring experiencing prenatal adverse stimuli, including maternal high-fat intake, 
maternal nicotine exposure and maternal protein restriction (Chisaka, et al., 2016; 
Resende, et al., 2013; Xiao, et al., 2015).  
In a PIE rat model with prenatal LPS exposure, ROS levels were found to be 
significantly increased, but no significant oxidative damage was found in both 
myocardial and vascular tissues in the offspring. However, under a second insult in 
adulthood, significant oxidative damage was found in the cardiovascular system in 
adults (Deng, Zhang, et al., 2016; Q. Zhang, et al., 2016). Interestingly, it seemed that 
two different mechanisms were involved in oxidative stress in response to a second 
insult between myocardial and vascular tissues in PIE offspring. In the myocardium 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
of adult PIE offspring, increased expression of both oxidase and antioxidant enzymes 
together with p38 mitogen-activated protein kinase (MAPK) activation maintained the 
relative modest ROS activation but without oxidative damage. As ISO could directly 
activate the p38 MAPK signal pathway through the G protein-coupled receptor 
(GPCR) (Magocsi, Vizi, Selmeczy, Brozik, & Szelenyi, 2007), a positive feedback 
loop between the p38 MAPK signal pathway and ROS was ignited when challenged 
with ISO as a second insult, augmenting the oxidative stress by the dramatic 
upregulation of NADPH (Q. Zhang, et al., 2016). In the vascular system, the 
PGC-1α-mediated antioxidant capacity was impaired by the NF-κB overactivation, 
but not the ROS-p38 MAPK-ROS positive feedback loop, which apparently was the 
key responsible pathway for the aggravated oxidative damage induced by the 
postnatal DOCA-salt treatment (Deng, Zhang, et al., 2016) (Fig. 4). 
4.1.3 Overactivation of the RAS in the cardiovascular system 
The RAS is a momentous endocrine, paracrine and intracrine vasoactive system 
that plays critical roles in the normal physiological regulation of cardiovascular 
functions and contributes to the development of cardiovascular, hypertensive, and 
renal diseases (Li, Zhang, & Zhuo, 2017). The RAS family mainly includes 
angiotensinogen, renin, angiotensin I, angiotensin-converting enzyme (ACE), ACE2, 
angiotensin II (Ang II), Ang II type 1 receptor (AT1R), and Ang II type 2 receptor 
(AT2R). Some of the key members of the RAS (including ACE, AT1R and AT2R) 
have already been developed as pharmacological targets to effectively treat heart, 
hypertensive and renal diseases (Bader, 2010). Plasma angiotensinogen is primarily 
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generated in the liver and is then converted into angiotensin I by kidney-derived renin 
in plasma. Ang I is then converted into Ang II by ACE, which is primarily present on 
endothelial cells. The actions of Ang II are then transmitted into the target cells by 
AT1R and AT2R, leading to an increase in blood volume and blood pressure via the 
stimulation of vasoconstriction, sodium retention, thirst, aldosterone synthesis and 
secretion from the adrenal cortex, and the sympathetic nervous system (Li, et al., 
2017). However, angiotensin could also be generated in local tissue, such as the brain, 
heart, blood vessels and kidney. Compared to the circulating RAS, the local RAS 
components are known to regulate the function of these organs and are involved in the 
tissue damage that eventually contributes to the pathogenesis of CVDs (e.g., 
hypertension) (Li, et al., 2017).  
In PIE-programmed CVD models, our laboratory has found that the circulating 
Ang II level is not altered in the offspring of LPS-treated mothers. However, the 
tissue Ang II, ACE and AT1R expression levels are significantly increased in the 
offspring’s kidneys (Hao, Kong, Zhang, & Zhao, 2013; Hao, Zhang, Li, et al., 2010), 
vascular system (He, et al., 2011), hearts (Y. Tang, Zhou, & Li, 2014) and adipose 
tissue (Gao, et al., 2014). Elevated local RAS activities are also found in the kidneys 
of offspring from zymosan-treated mothers (Hao, Zhang, Li, et al., 2010). In addition, 
the induction of proinflammatory factors by hyperglycemia exposure in utero alters 
the gene expression of RAS components in the offspring, which may in part account 
for the programmed hypertension (J. Yan, Li, Su, Zhang, & Yang, 2014).  
Interestingly, the intrarenal Ang II level is decreased in PIE neonates, suggesting 
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that the elevated RAS activity might be a secondary event of other signaling pathways. 
As we found that the prenatal or postnatal NF-κB inhibitor PDTC was able to reverse 
the RAS over-activation in the hearts (Y. Tang, et al., 2014), vascular tissues (Deng, 
Deng, et al., 2016) and kidneys (Guo, et al., 2016; Hao, Zhang, Li, et al., 2010), we 
believed that NF-B has crosstalk with RAS. In addition, Wang et al. found that 
administering 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-N-oxyl (TEMPOL) (a ROS 
scavenger) to PIE-offspring could also reverse RAS overactivity in the vascular 
system (X. Wang, et al., 2015). 
Taken together, the evidence in Section 4.1 suggests that the crosstalk among 
inflammation, oxidative stress and local RAS activity in cardiovascular tissues has 
important roles in the development of CVDs in PIE offspring, whereas the 
dysfunctional NF-κB signal pathway may act as a checkpoint in this process.  
 
4.2 Epigenetic reprograming 
Epigenetic mechanisms, such as DNA methylation, histone modification or 
noncoding RNA molecules, are believed to be involved in the developmental 
reprograming of adult diseases, especially metabolic syndrome and 
neuropsychological diseases caused by early life adverse exposure, which is well 
reviewed in several recent articles (Bale, 2015; Dunford & Sangster, 2017; Kirchner, 
Osler, Krook, & Zierath, 2013). DNA methylation and histone modification are 
believed to be involved in the development of and predisposition to metabolic 
diseases. For example, maternal and paternal periconceptional nutrition, such as 
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protein restriction or high-fat diets, alters the DNA methylation state of ribosomal 
DNA (rDNA) in germ cells, which is involved in the development of metabolic 
syndrome (Holland, et al., 2016). In a sheep model, maternal undernutrition leads to 
tissue-specific epigenetic modiﬁcation of the glucocorticoid receptor (GR) (including 
decreased GR promoter methylation, decreased histone lysine 27 trimethylation, and 
increased histone H3 lysine 9 acetylation) in different brain areas of adult offspring, 
participating in regulating the offspring’s energy balance (Begum, et al., 2013). 
Maternal obesity or weight loss altered the balance between “writers” and “erasers” of 
histone acetylation in the fetal liver and placental labyrinth, leading to fetal growth 
restriction in mice (Panchenko, et al., 2016).  
In animal models of PIE-programmed neurodevelopmental disorders, several 
studies have reported that PIE can provoke the alteration of enzymatic activities that 
are responsible for DNA methylation or histone modification (Reviewed in 
(Weber-Stadlbauer, 2017). Unfortunately, it has not been well-studied whether the 
potential changes of epigenetic regulation contribute to PIE-programmed CVDs. We 
made initial efforts to analyze the global DNA methylation level of the renal cortex, 
and we found it was dramatically increased in PIE-offspring (J. Wang, et al., 2017). 
Consistent with this finding, DNA methyltransferase (DNMT) 1 and DNMT3B, 
enzymes responsible for DNA methylation (Lyko, 2017), were found to be increased 
in renal tissue (J. Wang, et al., 2017). In addition, we found an increased level of 
histone H3 acetylation of the ACE promoter in the renal cortex of PIE-offspring (J. 
Wang, et al., 2016). This limited evidence suggests that epigenetic alteration is pivotal 
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for the development of PIE-programmed CVDs. It is important to further profile the 
changes in DNA methylation, histone modification or noncoding RNAs genome wide 
in the cardiovascular tissues in PIE-offspring (Fig. 5).  
 
4.3 Dysregulated immune system and HPA axis in PIE-offspring 
4.3.1 Reprogrammed immune system in PIE-offspring  
The immune response almost participates in every phase of CVD development 
and progression, including hypertension, atherosclerosis and heart disease. 
Overactivation of both the innate and the adaptive immune systems is involved in the 
damage of hypertensive end-organs, the formation and activation of atherosclerotic 
plaques, and cardiac injury (Epelman, Liu, & Mann, 2015; Rodriguez-Iturbe, Pons, & 
Johnson, 2017; Tabas & Lichtman, 2017).  
For the adaptive immune system, pregnant mice challenged with poly (I:C) at 
E12.5 (second trimester), a critical time window for the initiation of the immune 
system and hematopoietic stem cells (HSCs) during fetal development (Clements & 
Traver, 2013; Dzierzak & Speck, 2008), exhibit a significantly reduced total number 
of regulator T (Treg, CD4+CD25+Foxp3+) cells in the spleen but an increased 
production of IL-6 and IL-17 produced by CD4+ T cells (Hsiao, McBride, Chow, 
Mazmanian, & Patterson, 2012; Mandal, et al., 2013; Mandal, Marzouk, Donnelly, & 
Ponzio, 2010, 2011). When treated with zymosan (a TLR2 agonist) or MOG35-55 (an 
encephalitogenic peptide), the offspring also showed increased cellular and cytokine 
responses, respectively, which led to a preferential differentiation toward Th17 cells 
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(Mandal, et al., 2013). PIE-offspring treated with LPS at E12.5 also showed an 
elevated percentage of interferon (IFN)- γ+ and IL-17A+ CD4+ T cells in the spleen 
and liver (Luan, et al., 2015). At a later stage (E17.0) of treatment with LPS, the 
offspring also showed a similar trend with increased cell-mediated immunity, 
including increased levels of IL-12, IL-6 and IFN-γ when postnatally challenged with 
ovalbumin (Zager, Pinheiro, Ferraz-de-Paula, Ribeiro, & Palermo-Neto, 2013). These 
findings suggest a proinflammatory phenotype in PIE offspring, likely due to the 
alterations in development and/or immunological memory of the adaptive immune 
system.  
 Changes in the innate immune system have also been analyzed in PIE animal 
models. PIE-offspring from poly (I:C) treatment at E12.5 showed elevated levels of 
peripheral Gr-1+ cells in the spleen and increased myeloid lineage differentiation by 
HSCs (Hsiao, et al., 2012). Bone marrow-derived macrophages generated from the 
offspring of poly (I:C)-treated mothers showed an increased potential to differentiate 
into M1 macrophages, which suggests activated inflammatory macrophages in 
PIE-offspring (Onore, Schwartzer, Careaga, Berman, & Ashwood, 2014). 
In PIE-programmed CVDs, we found similar changes in PIE-offspring prenatally 
treated with poly (I:C) or LPS at E10.5, an earlier time window that is critical for 
HSC differentiation (Clements & Traver, 2013; Dzierzak & Speck, 2008), including a 
decreased abundance of Treg cells [Ji, Deng, et al., unpublished observation]. In 
addition, we also found an elevated ratio of matured dendritic cells and macrophages 
but a reduced ratio of monocytes in PIE-offspring prenatally treated with poly (I:C) or 
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LPS at E10.5 [Ji, Deng, et al., unpublished observation]. The alteration of the immune 
system in PIE-offspring is likely responsible for the atherosclerogenesis because the 
transfer of bone marrow cells from PIE-offspring prenatally treated with poly (I:C) or 
LPS to ApoE-deficient mice resulted in more atherosclerotic plaques in the aorta [Ji, 
Deng, et al., unpublished observation]. These findings suggest that dysregulation of 
both the innate and adaptive immune system contributes to the pathogenesis of 
PIE-programed CVDs.  
Due to the dramatic changes in both HSC and lymphocyte differentiation during 
different time windows of embryonic development (Clements & Traver, 2013; 
Dzierzak & Speck, 2008), the phenomenon of different alterations of immune cell 
subsets by different time points of inflammatory stimulation could be conceivable. 
For example, PIE-offspring prenatally treated with LPS at E12.5 showed a decreased 
number of Treg (CD4+ Foxp3+) cells in the thymus (Luan, et al., 2015), but 
PIE-offspring prenatally treated with poly (I:C) or LPS at E10.5 showed reduced 
numbers of Treg cells in the spleen [Ji, Deng, et al., unpublished observation]. 
However, the overall proinflammatory phenotype due to the imbalanced immune 
homeostasis exists in the offspring of PIE models, which merits further studies to find 
the common initiating factors responsible for the imbalanced immune homeostasis. 
This research will help to elucidate the mechanisms of PIE-programmed CVDs (Fig. 
5). 
4.3.2 Dysregulation of HPA axis activity in PIE-offspring 
Exposure to environmental, physical, or physiological stresses causes systematic 
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activation of various biological stress responses. The stress response, including the 
endocrine, immune, and cardiovascular systems, comprises a complex interaction 
between components of the central nervous system (CNS) and peripheral systems 
(Kadmiel & Cidlowski, 2013; Selye, 1956). The HPA axis, including the 
paraventricular nucleus (PVN) of the hypothalamus, the anterior pituitary gland, and 
the cortex of the adrenal gland, plays a critical role in homeostatic maintenance in 
response to stress through regulating adrenal hormones and glucocorticoids. Stress 
can activate the hypophysiotropic neurons in the PVN that can release 
corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP). CRH and 
AVP travel through the median eminence and hypophyseal portal vessels and reach 
the anterior pituitary, where they stimulate the synthesis and secretion of 
adrenocorticotropic hormone (ACTH). ATCT reaches the zona fasciculata of the 
adrenal cortex and promotes the synthesis and release of the primary stress hormones, 
namely, glucocorticoids (Burford, Webster, & Cruz-Topete, 2017). Through 
circulation, glucocorticoids reach various cardiovascular tissues (such as the heart, 
vasculature, adipose tissue, and muscle) and bind to the GR, which triggers beneficial 
actions on the cardiovascular function, immune system, and secondary metabolism in 
response to stress. Glucocorticoids could also create negative feedback to inhibit 
activation of the HPA axis through their levels in the hypothalamus and pituitary 
gland (Burford, et al., 2017). However, if there is sustained elevation of 
glucocorticoid levels induced by chronic stress, the levels of CVD incidence will 
increase (Burford, et al., 2017; Kadmiel & Cidlowski, 2013); similarly, the incidence 
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of metabolic diseases and psychiatric symptoms will increase as well (Chrousos, 2009; 
Constantinof, Moisiadis, & Matthews, 2016).  
The activity of the HPA axis is dramatically affected by pregnancy, causing 
increased cortisol and ACTH levels during gestation (J. R. Lindsay & Nieman, 2005). 
The activity of the HPA axis is highly susceptible to maternal adverse stimulants such 
as alcohol (X. Zhang, Sliwowska, & Weinberg, 2005), a protein-restricted diet 
(Bertram, Trowern, Copin, Jackson, & Whorwood, 2001; Langley-Evans, 1997; 
Langley-Evans, Gardner, & Jackson, 1996), a high-fat diet (Sasaki, de Vega, St-Cyr, 
Pan, & McGowan, 2013), smoking (McDonald, et al., 2006; Stroud, et al., 2014), 
preeclampsia (Henley, Brown, Pennell, Lye, & Torpy, 2016), which contribute to 
many CVDs (van Montfoort, Finken, le Cessie, Dekker, & Wit, 2005). Direct 
evidence shows that early- life overactivation of the HPA axis by excessive maternal 
glucocorticoids exposure leads to reprograming of the HPA axis in offspring and 
elevates their incidence of CVDs, such as hypertension (Edwards, Benediktsson, 
Lindsay, & Seckl, 1993; R. S. Lindsay, Lindsay, Edwards, & Seckl, 1996; J. I. Tang, 
Kenyon, Seckl, & Nyirenda, 2011). Several studies have revealed that PIE contributes 
to the reprogramming of the HPA axis. Epidemiological investigations indicate that 
infants exposed to chorioamnionitis with funisitis show increased levels of salivary 
cortisol at the corrected age of 18 months compared to  infants with no infections or 
chorioamnionitis alone (Gover, et al., 2013). In a rat animal model, prenatal IL-6 
exposure resulted in hypertension and dysregulation of HPA axis activity in adult rats, 
such as reducing the mRNA expression of the mineralocorticoid receptor (Nr3c2) and 
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glucocorticoid receptor (Nr3c1) in the hippocampus and increasing the 
corticotropin-releasing factor (CRF) level in the hypothalamus and CRF receptor type 
1 (Crhr1) mRNA expression in the pituitary (Samuelsson, et al., 2004). Prenatal LPS 
exposure leads to an increase in maternal corticosterone levels (Babri, Doosti, & 
Salari, 2014; Kirsten, Lippi, Bevilacqua, & Bernardi, 2013) and heightens the 
corticosterone responses in adult PIE-offspring (Lin, Lin, & Wang, 2012).  
The altered crosstalk between the immune response and the HPA axis has 
important roles in the development and progression of CVDs. For example, 
psychological stress induces atherosclerosis, and under psychological stress, 
activation of the HPA and sympathetic adrenal medullary (SAM) axes activates 
immune reactions in immune cells, which results in elevated levels of 
proinflammatory cytokines, such as IL-1β, TNF-α and IL-6. These proinflammatory 
cytokines can change the level of stress hormones, which leads to either activation or 
suppression of the HPA or SAM regulatory feedback loop. If the positive feedback 
between the immune response and the HPA axis is established, it will damage the 
vascular endothelium function and increase the recruitment of circulating monocytes 
and their conversion into foam cells (Gu, Tang, & Yang, 2012). Given the evidence 
that fetal programming of the HPA-immune system plays critical roles in the 
development of metabolic diseases (Fisher, Steele, & Karrow, 2012), it is conceivable 
that analyzing details of the HPA-immune system will provide more potential targets 
for developing a therapeutic intervention for PIE-programmed CVDs (Fig. 5).  
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4.4 Immuno-inflammatory changes at the maternal-fetus interface of PIE models 
The placental origin of various adult chronic diseases has been extensively 
studied and well appreciated in previous studies (Burton, et al., 2016). The placenta is 
the organ that performs various activities (including nutrient transport and endocrine 
functions) and forms the interface between the fetus and its mother, underpinning 
fetal development. The maternal- fetus interface acts as a physical barrier, impeding 
the entry of pathogens and some maternal immune molecules and immune cells into 
the fetal circulation (Burton, et al., 2016). A dysfunctional placenta leads to 
insufficient nutrients or excessive unneeded materials arriving at the fetus, which 
causes embryonic defects or embryonic development reprogramming, resulting in 
future postnatal chronic diseases. For example, mothers treated with glucocorticoids 
exhibited reduced activity of 11β-hydroxysteroid dehydrogenase (HSD) in the 
placenta, followed by exposure of the fetus to excess levels of glucocorticoids, which 
is associated with adult hypertension (Edwards, et al., 1993).  
Elevated levels of the placental inﬂammation response may have some adverse 
effects on placental transport capacity, infiltration of immune cells, and placental 
hemorrhage (Abrahams, et al., 2005; Baines, Duclos, Antecka, & Haddad, 1997; 
Huang, et al., 2008; Kim, et al., 2015; Liong & Lappas, 2017; H. Zhao, et al., 2015). 
These effects in turn will lead to intrauterine growth restriction, low birth weight, and 
higher proinflammatory cytokines in the fetus, which is also associated with adult 
CVDs (Bukowski, et al., 2017; Burton, et al., 2016; Straughen, et al., 2017). 
In PIE rat models, there are several direct lines of evidence supporting this 
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hypothesis. Prenatal exposure to LPS or poly (I:C) leads to robustly elevated levels of 
proinflammatory cytokines, such as TNF-α, IL-1β, IL-6 and IL-10 in the placenta and 
amniotic ﬂuid, irrespective of the high or low dose of inflammatory stimulants 
(Ashdown, et al., 2006; Cai, Pan, Pang, Evans, & Rhodes, 2000; Deng, Deng, et al., 
2016; Urakubo, et al., 2001). In other chronic inflammatory statuses during pregnancy, 
smoking mothers have more natural killer cells and inflammatory macrophages in the 
first-trimester decidua (Prins, et al., 2012); obesity in pregnancy can stimulate the 
accumulation of macrophage and proinflammatory mediators in the placenta (Challier, 
et al., 2008). The similar changes in the placenta as those in PIE models further 
support our idea that the chronic inflammatory status caused by other diseases during 
pregnancy, such as obesity, diabetes, hyperglycemia, hypertension, preeclampsia, and 
smoking, plays critical roles in mediating the development of CVDs in adults. 
However, the ratio and functional changes of each immune cell subset in the placenta 
after PIE challenge and the role of these changes in the development of 
PIE-programmed CVDs are still largely unknown.  
 
5. Potential preventive strategies for PIE-programmed CVDs  
Timely symptom-based treatments for CVDs are beneficial, but such treatments 
have a limited degree or are often too late to be effective. Interventions in young and 
even fetal individuals are now believed to be more effective and lower the risk factors 
in the next generation via the reproductive cells (Hanson & Gluckman, 2014). 
Therefore, an increasing number of countries, especially those with aging societies, 
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have adopted an important measure for early- life prevention of NCDs. As a successful 
example, the intense promotion of breastfeeding initiated by East Germany yielded a 
lower prevalence of obesity in young individuals compared to that in the 
corresponding West Berlin population, which was not introduced to intense 
breastfeeding (Dörner, Rodekamp, & Plagemann, 2008). 
There are some limited exploratory studies seeking potential effective preventive 
strategies during pregnancy or in young offspring by using PIE animal models. We 
found that pharmacological treatments in the second trimester with PDTC could 
effectively prevent PIE-programmed hypertension, vascular damage (Deng, Deng, et 
al., 2016; Hao, Zhang, Yuan, et al., 2010), and myocardial remodeling (Chen, et al., 
2015; Y. Wei, et al., 2013) in rats. Interestingly, early postnatal treatment with PDTC, 
NAC, or TEMPOL could also prevent PIE-programmed CVDs (Deng, Deng, et al., 
2016; Deng, Zhang, et al., 2016; X. Wang, et al., 2014; X. Wang, et al., 2015; Q. 
Zhang, et al., 2016), suggesting that both prenatal and early postnatal life can be 
considered the therapeutic window for the prevention of PIE-CVDs.  
As the concept of DOHaD has been accepted in our community, the avoidance of 
various adverse insults during gestation seems obvious to preclude PIE-programmed 
CVDs. Some risk factors are easier to control, such as avoiding malnutrition, smoking, 
and the intake of nicotine, ethanol and caffeine. The more difficult measure to prevent 
PIE-programmed CVDs is the control of infection-induced inflammation or chronic 
inflammatory states due to various disease conditions during pregnancy. Therefore, 
the first and critical step for the eventual identification of preventative and therapeutic 
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strategies is to determine the complex molecular pathogenic mechanisms that underlie 
the early development of various NCDs. Another important challenge for us is to 
search for specific diagnostic biomarkers (including various proinflammatory 
cytokines) in both maternal serum and umbilical cord blood after a definite 
inflammatory challenge in individuals who have the potential for developing 
PIE-programmed CVDs. Given the limitations of screening for targets in humans, PIE 
animal models become an important resource, especially with respect to their 
usefulness for comparing the types and differences of PIE-programmed CVDs 
triggered at various time windows during pregnancy. Such research will help us to 
understand the vulnerability of infected individuals to various PIE-programmed 
CVDs. 
Hence, we need to focus our efforts on the disease-causing mechanisms and 
search for specific diagnostic biomarkers to develop a universal therapeutic strategy 
for the prevention of PIE-programmed CVDs, especially from the aspect of 
stress-response and hormone-secretion regulation in both the mother and offspring. 
Our future studies in this important field will provide a great opportunity to uncover 
novel interventions by managing the adverse effects of inflammation in prepregnant 
and pregnant individuals who are at risk for PIE-programmed CVDs.  
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Tables 
Table 1 Epidemiological studies linking maternal insults with diseases in offspring 
Key studies Maternal 
insults 
Offspring 
disease 
Country Major findings 
Boggess et 
al., 2006 
Periodontal 
disease 
Preterm birth, 
low birth 
weight 
USA Moderate or severe 
periodontal disease 
early in pregnancy is 
associated with the 
delivery of a 
small-for-gestational-ag
e infant. 
Hay et al., 
1994 
Bacterial 
infection 
Preterm 
delivery 
England Late miscarriage and 
preterm delivery are 
associated with the 
presence of bacterial 
vaginosis in early 
pregnancy. 
Arends et al., 
2005 
Preterm 
birth 
Type 2 
diabetes 
mellitus and 
cardiovascular 
diseases 
Netherland
s 
The development of 
type 2 diabetes mellitus 
and CVDs are already 
present during 
childhood in short 
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prepubertal children 
born small for 
gestational age (SGA). 
Erikssonet 
al., 2016 
Low birth 
height and 
weight 
Heart disease, 
type 2 
diabetes 
Finland Early growth patterns 
are associated with 
coronary heart disease, 
type 2 diabetes and 
other health outcomes. 
Cocoros et 
al., 2014 
Inﬂuenza Cardiovascula
r events 
Danish Prenatal exposure to the 
1918 influenza 
pandemic is associated 
with cardiovascular 
events in adulthood. 
Mazumder et 
al., 2010 
Inﬂuenza CVDs USA Maternal infections in 
the fetus result in the 
programming of 
cardiovascular risk 
factors that are 
independent of maternal 
malnutrition. 
Myrskyla et 
al., 2013 
Inﬂuenza Respiratory 
and 
National 
Health 
Early disease exposure 
increases old-age 
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cardiovascular 
diseases 
Interview 
Survey 
mortality through 
noncancer causes, 
which include 
respiratory and 
cardiovascular diseases. 
Acs et al., 
2005 
Inﬂuenza Cardiovascula
r congenital 
abnormalities 
 Maternal inﬂuenza 
during pregnancy 
results in the risk of 
congenital 
abnormalities in 
offspring. 
Ou, et al., 
2016 
Fever, 
diabetes, 
influenza, 
and 
threatened 
abortion 
Congenital 
heart defects 
China Maternal fever, diabetes 
and influenza are 
dominant risk factors 
associated with 
congenital heart defects. 
Botto, et al., 
2014 
Febrile 
genitourinar
y infections 
Congenital 
heart defects 
USA Febrile genitourinary 
infections are associated 
with selected heart 
defects, particularly 
right-sided obstructive 
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defects. 
Mazumder et 
al., 2010 
Inﬂuenza Ischemic heart 
disease 
USA Prenatal exposure to the 
1918 influenza 
pandemic resulted in 
≥20% excess 
cardiovascular diseases 
in the offspring at 60 to 
82 years of age. 
Aceti et al., 
2012 
Type 2 
diabetic 
Higher 
systolic blood 
pressure 
 Offspring of diabetic 
mothers have a higher 
systolic BP than 
controls. 
Roberts et 
al., 2015 
Obesity CVDs  Maternal obesity during 
pregnancy results in a 
subsequent impact on 
fetal cardiovascular 
development. 
Tenhola et 
al., 2006 
Preeclampsi
a 
Hypertension Kuopio Maternal preeclampsia 
is associated with 
elevated BP in 
offspring. 
Himmelman Hypertensio Higher blood Sweden Maternal histories of 
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n et al., 
1993, 1994 
n pressure hypertension maintain 
their rank with regard to 
left ventricular mass 
during adolescence. 
Jayet, et al., 
2010 
Preeclampsi
a 
 
Pulmonary 
and systemic 
vascular 
dysfunction 
Switzerlan
d 
Preeclampsia leaves a 
persistent defect in the 
systemic and pulmonary 
circulation of the 
offspring. 
Lazdam et 
al., 2012 
Preeclampsi
a 
Hypertension England Mothers who develop 
early-onset 
preeclampsia and the 
offspring of these 
pregnancies display 
specific adverse 
blood-pressure 
characteristics later in 
life. 
Lim et al., 
2015 
Hypertensio
n 
Hypertension Singapore Maternal central 
pulsatile blood pressure 
components (SBP and 
PP) during pregnancy 
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are associated with 
higher blood pressures 
in offspring.  
Cohen et al., 
2008 
Smoking Hypertension Sweden There is early postnatal 
programming of human 
cardiovascular 
dysfunction by maternal 
smoking. 
Lawlor, et 
al., 2004 
Smoking Hypertension Switzerlan
d 
Childhood blood 
pressure tracks into 
adulthood; interventions 
are aimed at early-life 
risk factors, such as 
quitting smoking during 
pregnancy. 
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Table 2 Experimental animal models for PIE-programmed CVDs 
Animal model Disease 
phenotypes 
Reported molecular 
mechanism 
Age at 
evaluation 
Ref. 
Pregnant rats 
injected with 
human IL-6 
during the 
entire second 
or third 
trimester 
Higher blood 
pressure 
Not studied 5 and 11 
weeks 
Samuelsson, 
et al., 2004，
2006 
Pregnant rats 
treated with 
LPS or 
zymosan on 
gestational 
days 8, 10 and 
12 
Higher blood 
pressure 
Not studied 6 weeks of 
age and 
older  
Liao, et al., 
2008; Y. L. 
Wei, Li, & 
Zhou, 2007 
Prenatal rats 
injected with 
LPS in the 
second 
trimester 
Endothelium 
dysfunction in 
thoracic aortas; 
hypertension 
NF-κB 
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Figure Legends 
Fig. 1. Direct and indirect epidemiological evidence for PIE-programed CVDs. 
Timeline of the initial reported epidemiological studies for both direct and indirect 
evidence for PIE-programed CVDs. The direct evidence from the cohorts with 
prenatal influenza exposure indicates that the second trimester of gestation is the most 
sensitive time window for PIE-programed CVDs. 
Abbreviations: CVDs, cardiovascular diseases; PIE, prenatal inflammatory exposure. 
Fig. 2. Both systemic maternal or placental “hot” and “cold” inflammation are 
associated with adult CVDs in offspring. This schematic summarizes the etiologies 
for both maternal systemic or placental “hot” and “cold” inflammation associated 
with PIE-associated CVDs. Abbreviations: CMV, cytomegalovirus; CVDs, 
cardiovascular diseases; HBV, hepatitis B virus; HIV, human immunodeﬁciency virus; 
HPV, human papillomavirus; HRV, human rhinovirus; HSV, herpes simplex virus; PIE, 
prenatal inflammatory exposure. 
Fig. 3. Animal models for PIE-programed CVDs. This schematic depicts the current 
models for PIE-programed CVDs with the injection of LPS (Y. L. Wei, et al., 2007), 
Poly (I:C) [Guan, Deng, et al. Unpublished data], zymosan (Liao, et al., 2008) or IL-6 
(Samuelsson, et al., 2006; Samuelsson, et al., 2004) at the indicated time points during 
pregnancy by using a rat or mouse. The time points for the onset of circulation and 
occurrence of primitive macrophages, aortic clusters, AGM and HSCs are also added 
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to the timeline of pregnancy (Clements & Traver, 2013; Dzierzak & Speck, 2008).  
Abbreviations: AGM, aorta-gonad-mesonephros; CVDs, cardiovascular diseases; 
HSCs, hematopoietic stem cells; PIE, prenatal inflammatory exposure. 
Fig. 4. Proposed model of PIE as a CVDs primer. Early- life NF-κB dyshomeostasis 
plays essential roles in the aging-related development of hypertension and heart 
diseases through triggering the crosstalk among inflammation, RAS overactivity and 
ROS activation (Deng, Deng, et al., 2016; Deng, Zhang, et al., 2016; Y. Wei, et al., 
2013). Two different mechanims may be involved in oxidative stress responding to a 
second insult between myocardial and vascular tissues in PIE offspring. In the heart, 
the positive feedback loop between the p38 MAPK signal pathway and ROS is ignited 
when challenged with ISO as a second insult, augmenting oxidative stress by 
dramatically upregulating the expression of NADPH oxidase (Q. Zhang, et al., 2016). 
However, in the vasculature, NF-κB overactivation impairing the PGC-1α-mediated 
antioxidant capacity, but not the p38 MAPK-ROS positive feedback loop, is the key 
responsible pathway for the aggravated oxidative damage by DOCA-salt treatment at 
the adult stage (Deng, Zhang, et al., 2016). 
Abbreviations: CVDs, cardiovascular diseases; DOCA-salt, deoxycorticosterone 
acetate (DOCA) and salt; ISO, isoproterenol; MAPK, mitogen-activated protein 
kinase; PIE, prenatal inflammatory exposure; RAS, renin–angiotensin system; ROS, 
reactive oxygen species.  
Fig. 5. Mechanisms underlying PIE-programed CVDs. Schematic representation of 
the multiple signal pathways (such as inflammation, oxidative stress, RAS, NF-κB 
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and epigenetic reprograming) in cardiovascular tissues and the dysregulation of the 
immune system and HPA axis, which may predispose PIE offspring to CVDs. ↑ 
indicates upregulation of protein expression or increased cell abundance; ↓ indicates 
downregulation of protein expression or decreased cell abundance.  
Abbreviations: ACE, angiotensin-converting enzyme; Ang II, angiotensin II; AT1R, 
Ang II type 1 receptor; CRF, corticotropin-releasing factor; CRFR, hypothalamus and 
CRF receptor type 1 (Crhr1); CVDs, cardiovascular diseases; DNMT, DNA 
methyltransferase; GR, glucocorticoid receptors; HPA, hypothalamic-pituitary-adrenal; 
MR, mineralocorticoid receptors; PIE, prenatal inflammatory exposure; RAS, renin–
angiotensin system; ROS, reactive oxygen species; Treg, regulator T; Th17, T helper 
cell type 17.  
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